Pfizer Inc. buy Guggenheim
Start price
18.03.25
/
50%
€24.09
Target price
18.03.26
-
Performance (%)
-1.62%
End price
19.03.26
€23.70
Summary
This prediction ended on 19.03.26 with a price of €23.70. With a performance of -1.62%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 5.208% | 5.208% | 10.557% |
| iShares Core DAX® | 1,84 % | 1,39 % | 8,65 % |
| iShares Nasdaq 100 | 4,66 % | -1,80 % | 27,82 % |
| iShares Nikkei 225® | 3,96 % | -5,22 % | 51,81 % |
| iShares S&P 500 | 3,70 % | 1,58 % | 24,09 % |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten